GT Biopharma Inc
NASDAQ:GTBP
Income Statement
Earnings Waterfall
GT Biopharma Inc
Revenue
|
0
USD
|
Operating Expenses
|
-13.6m
USD
|
Operating Income
|
-13.6m
USD
|
Other Expenses
|
6m
USD
|
Net Income
|
-7.6m
USD
|
Income Statement
GT Biopharma Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
-24%
|
0
-11%
|
0
-72%
|
0
-14%
|
0
+17%
|
0
-14%
|
0
N/A
|
0
-50%
|
0
-33%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
-14%
|
0
-25%
|
0
-67%
|
0
N/A
|
0
N/A
|
0
+50%
|
0
N/A
|
0
N/A
|
0
-33%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(5)
|
(8)
|
(9)
|
(11)
|
(12)
|
(11)
|
(9)
|
(7)
|
(6)
|
(131)
|
(136)
|
(141)
|
(145)
|
(24)
|
(22)
|
(247)
|
(244)
|
(14)
|
(11)
|
(13)
|
(8)
|
(5)
|
(7)
|
(49)
|
(38)
|
(42)
|
(58)
|
(34)
|
(33)
|
(34)
|
(21)
|
(19)
|
(20)
|
(16)
|
(14)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(5)
|
(7)
|
(8)
|
(10)
|
(10)
|
(10)
|
(8)
|
(6)
|
(5)
|
(129)
|
(135)
|
(137)
|
(138)
|
(16)
|
(12)
|
(12)
|
(12)
|
(11)
|
(10)
|
(7)
|
(7)
|
(5)
|
(6)
|
(33)
|
(35)
|
(38)
|
(48)
|
(24)
|
(22)
|
(21)
|
(12)
|
(11)
|
(11)
|
(8)
|
(7)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(7)
|
(8)
|
(9)
|
(6)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(2)
|
(2)
|
(4)
|
(10)
|
(10)
|
(11)
|
(12)
|
(9)
|
(8)
|
(9)
|
(8)
|
(6)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(229)
|
(229)
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(1)
N/A
|
(1)
+32%
|
(1)
-6%
|
(1)
-72%
|
(2)
-145%
|
(4)
-71%
|
(5)
-32%
|
(8)
-41%
|
(9)
-17%
|
(11)
-23%
|
(12)
-6%
|
(11)
+2%
|
(9)
+18%
|
(7)
+25%
|
(6)
+12%
|
(131)
-2 012%
|
(136)
-4%
|
(141)
-4%
|
(145)
-3%
|
(24)
+83%
|
(22)
+12%
|
(247)
-1 046%
|
(244)
+1%
|
(14)
+94%
|
(11)
+16%
|
(13)
-14%
|
(8)
+41%
|
(5)
+30%
|
(7)
-24%
|
(49)
-620%
|
(38)
+23%
|
(42)
-11%
|
(58)
-39%
|
(34)
+41%
|
(33)
+4%
|
(34)
-3%
|
(21)
+37%
|
(19)
+8%
|
(20)
-3%
|
(16)
+19%
|
(14)
+16%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
(1)
|
(1)
|
(4)
|
(21)
|
(40)
|
(11)
|
(6)
|
(13)
|
25
|
0
|
(2)
|
19
|
(3)
|
(8)
|
(10)
|
(9)
|
(8)
|
(11)
|
(8)
|
(9)
|
(7)
|
(3)
|
(3)
|
(2)
|
(2)
|
(7)
|
(7)
|
(3)
|
(3)
|
1
|
2
|
(1)
|
0
|
1
|
0
|
0
|
3
|
5
|
5
|
1
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(229)
|
(229)
|
0
|
0
|
(5)
|
(5)
|
0
|
(16)
|
(11)
|
(5)
|
0
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(20)
|
(20)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20)
|
(20)
|
0
|
(13)
|
(13)
|
(13)
|
(13)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
Pre-Tax Income |
(1)
N/A
|
(1)
-147%
|
(1)
+3%
|
(5)
-281%
|
(24)
-350%
|
(44)
-86%
|
(17)
+62%
|
(14)
+15%
|
(21)
-53%
|
14
N/A
|
(12)
N/A
|
(14)
-17%
|
10
N/A
|
(10)
N/A
|
(14)
-40%
|
(141)
-908%
|
(144)
-2%
|
(149)
-3%
|
(156)
-4%
|
(261)
-67%
|
(259)
+1%
|
(254)
+2%
|
(247)
+2%
|
(41)
+83%
|
(39)
+7%
|
(36)
+7%
|
(50)
-41%
|
(23)
+53%
|
(28)
-21%
|
(65)
-129%
|
(52)
+19%
|
(55)
-5%
|
(58)
-6%
|
(34)
+42%
|
(32)
+6%
|
(33)
-4%
|
(21)
+37%
|
(16)
+25%
|
(15)
+6%
|
(10)
+30%
|
(8)
+26%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(1)
|
(1)
|
(1)
|
(5)
|
(24)
|
(44)
|
(17)
|
(14)
|
(21)
|
14
|
(12)
|
(14)
|
10
|
(10)
|
(14)
|
(141)
|
(144)
|
(149)
|
(156)
|
(261)
|
(259)
|
(254)
|
(247)
|
(41)
|
(39)
|
(36)
|
(50)
|
(23)
|
(28)
|
(65)
|
(52)
|
(55)
|
(58)
|
(34)
|
(32)
|
(33)
|
(21)
|
(16)
|
(15)
|
(10)
|
(8)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(1)
N/A
|
(1)
-168%
|
(1)
+3%
|
(5)
-300%
|
(23)
-352%
|
(44)
-86%
|
(17)
+62%
|
(14)
+15%
|
(21)
-53%
|
14
N/A
|
(12)
N/A
|
(14)
-17%
|
10
N/A
|
(10)
N/A
|
(14)
-40%
|
(141)
-908%
|
(144)
-2%
|
(149)
-3%
|
(156)
-4%
|
(261)
-67%
|
(259)
+1%
|
(254)
+2%
|
(247)
+2%
|
(41)
+83%
|
(39)
+7%
|
(36)
+7%
|
(50)
-41%
|
(23)
+53%
|
(28)
-21%
|
(65)
-129%
|
(52)
+19%
|
(55)
-5%
|
(58)
-6%
|
(34)
+42%
|
(32)
+6%
|
(33)
-4%
|
(21)
+37%
|
(16)
+25%
|
(15)
+6%
|
(10)
+30%
|
(8)
+26%
|
|
EPS (Diluted) |
-1 113.27
N/A
|
-2 771.87
-149%
|
-2 909.11
-5%
|
-11 326.91
-289%
|
-51 515.27
-355%
|
-93 887.12
-82%
|
-65 358.86
+30%
|
-59 829.87
+8%
|
-45 711.35
+24%
|
-26 845.04
+41%
|
-54 479.69
-103%
|
-1 352
+98%
|
2 038.62
N/A
|
-998
N/A
|
-466
+53%
|
-149.97
+68%
|
-145.62
+3%
|
-50.57
+65%
|
-52.82
-4%
|
-88.46
-67%
|
-87.56
+1%
|
-84.25
+4%
|
-81.08
+4%
|
-11.96
+85%
|
-11.42
+5%
|
-8.7
+24%
|
-11.93
-37%
|
-5.2
+56%
|
-6.45
-24%
|
-3.99
+38%
|
-1.56
+61%
|
-1.75
-12%
|
-2.06
-18%
|
-1.03
+50%
|
-1.02
+1%
|
-1.06
-4%
|
-0.66
+38%
|
-0.4
+39%
|
-0.36
+10%
|
-0.24
+33%
|
-5.64
-2 250%
|